Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Invasive aspergillosis in chronic granulomatous disease.

Segal BH, Romani LR.

Med Mycol. 2009;47 Suppl 1:S282-90. doi: 10.1080/13693780902736620. Epub 2009 Mar 18. Review.

PMID:
19296367
2.

Invasive aspergillosis in primary immunodeficiencies.

Almyroudis NG, Holland SM, Segal BH.

Med Mycol. 2005 May;43 Suppl 1:S247-59. Review.

PMID:
16110817
3.

Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.

Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, Zelante T, Vacca C, Bistoni F, Fioretti MC, Grohmann U, Segal BH, Puccetti P.

Nature. 2008 Jan 10;451(7175):211-5. doi: 10.1038/nature06471.

PMID:
18185592
4.
5.

Role of NADPH oxidase in host defense against aspergillosis.

Grimm MJ, Vethanayagam RR, Almyroudis NG, Lewandowski D, Rall N, Blackwell TS, Segal BH.

Med Mycol. 2011 Apr;49 Suppl 1:S144-9. doi: 10.3109/13693786.2010.487077. Epub 2010 Jun 21.

PMID:
20560866
7.

Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.

Bianchi M, Niemiec MJ, Siler U, Urban CF, Reichenbach J.

J Allergy Clin Immunol. 2011 May;127(5):1243-52.e7. doi: 10.1016/j.jaci.2011.01.021. Epub 2011 Mar 3.

PMID:
21376380
8.
9.
10.

A case of invasive aspergillosis in CGD patient successfully treated with Amphotericin B and INF-gamma.

Mamishi S, Zomorodian K, Saadat F, Gerami-Shoar M, Tarazooie B, Siadati SA.

Ann Clin Microbiol Antimicrob. 2005 Mar 3;4:4.

11.

Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.

Dennis CG, Greco WR, Brun Y, Youn R, Slocum HK, Bernacki RJ, Lewis R, Wiederhold N, Holland SM, Petraitiene R, Walsh TJ, Segal BH.

Antimicrob Agents Chemother. 2006 Feb;50(2):422-7.

12.

Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction.

Henriet SS, Verweij PE, Warris A.

J Infect Dis. 2012 Oct 1;206(7):1128-37. doi: 10.1093/infdis/jis473. Epub 2012 Jul 24. Review.

13.

Refractory invasive aspergillosis controlled with posaconazole and pulmonary surgery in a patient with chronic granulomatous disease: case report.

Kepenekli E, Soysal A, Kuzdan C, Ermerak NO, Yüksel M, Bakır M.

Ital J Pediatr. 2014 Jan 8;40:2. doi: 10.1186/1824-7288-40-2.

14.

Resistant invasive aspergillosis in an autosomal recessive chronic granulomatous disease.

Sfaihi L, Maaloul I, Fourati H, Stasia MJ, Mnif Z, Hachicha M.

Fetal Pediatr Pathol. 2013 Jul;32(4):241-5. doi: 10.3109/15513815.2012.721479. Epub 2012 Sep 24.

PMID:
23002911
15.

Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease.

Liu W, Yan M, Sugui JA, Li H, Xu C, Joo J, Kwon-Chung KJ, Coleman WG, Rodgers GP.

J Clin Invest. 2013 Sep;123(9):3751-5. doi: 10.1172/JCI68453. Epub 2013 Aug 1.

16.

Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease.

Henriet SS, Jans J, Simonetti E, Kwon-Chung KJ, Rijs AJ, Hermans PW, Holland SM, de Jonge MI, Warris A.

J Infect Dis. 2013 Jun 15;207(12):1932-9. doi: 10.1093/infdis/jit103. Epub 2013 Mar 12.

17.

Chronic granulomatous disease: lessons from a rare disorder.

Segal BH, Veys P, Malech H, Cowan MJ.

Biol Blood Marrow Transplant. 2011 Jan;17(1 Suppl):S123-31. doi: 10.1016/j.bbmt.2010.09.008. Review.

18.
19.
20.

Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.

Bielorai B, Toren A, Wolach B, Mandel M, Golan H, Neumann Y, Kaplinisky C, Weintraub M, Keller N, Amariglio N, Paswell J, Rechavi G.

Bone Marrow Transplant. 2000 Nov;26(9):1025-8.

Items per page

Supplemental Content

Write to the Help Desk